跳到正文
cccskills
免费在 GitHub 公开

es-cushing-localize-resect-ectopic-acth-tumors

This skill recommends localizing and resecting ectopic ACTH-secreting tumors with node dissection when ectopic ACTH secretion is suspected or confirmed. Clinical triggers include unexplained persistent hypercortisolism after pituitary surgery, elevated ACTH with negative pituitary MRI, or identification of occult ectopic ACTH syndrome (EAS) on biochemical testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL
查看安装方法

包含的文件（1）

  • SKILL.md2.9 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Localizing and Resecting Ectopic ACTH-Secreting Tumors with Node Dissection

STEP 1 — Gather Information

Confirm biochemical hypercortisolism (elevated UFC or late-night salivary cortisol) and elevated ACTH; obtain pituitary MRI to exclude adenoma; perform inferior petrosal sinus sampling (IPSS) to assess central vs peripheral ACTH source; if peripheral, pursue anatomic imaging (contrast-enhanced CT chest/abdomen/pelvis, somatostatin receptor PET/CT, or Ga-68 DOTATATE) to localize tumor; document size, location, and presence of metastatic nodes.

STEP 2 — Rule In / Rule Out

Is ectopic ACTH secretion confirmed by peripheral IPSS gradient and/or identification of a tumor on imaging? If yes, proceed to localization and resection planning; if no, reconsider Cushing’s disease or adrenal etiology and repeat biochemical testing or pursue alternative diagnostic pathways.

STEP 3 — Classify or Stratify

Classify the ectopic ACTH source as occult (no lesion on conventional CT/MRI but positive functional imaging) versus metastatic (radiographically evident lymph node or distant metastases); this determines extent of surgical dissection needed.

STEP 4 — Decide

For localized occult or resectable metastatic ectopic ACTH tumors, recommend en bloc surgical resection with systematic mediastinal or abdominal lymph node dissection; for unresectable widespread metastasis, consider medical therapy (ketoconazole/metyrapone) or bilateral adrenalectomy as a life-preserving measure while awaiting systemic treatment.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on pituitary MRI; false-negative IPSS can misdirect to pituitary surgery; avoid resection without histologic confirmation when possible; neglecting node dissection increases recurrence risk; proceed to surgery only after multidisciplinary review (endocrinology, thoracic surgery, nuclear medicine); avoid empiric medical therapy without localization in operable disease.

Concrete Clinical Example

A 48‑year‑old with refractory hypertension, hyperglycemia, and hypokalemia had UFC 3× ULN and ACTH 120 pg/mL; pituitary MRI was negative; IPSS showed peripheral gradient; CT chest revealed a 1.5 cm bronchial carcinoid; video‑assisted thoracoscopic resection with mediastinal lymph node dissection yielded normal postoperative UFC and ACTH; patient remained eucortisolemic at 6‑month follow‑up.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题